NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells (2022)
Source: Scientific Reports. Unidades: FMRP, ICB, FM
Subjects: FARMACOLOGIA, NEOPLASIAS PULMONARES, ANTINEOPLÁSICOS, NEOPLASIAS PULMONARES, ANTINEOPLÁSICOS, CÉLULAS CULTIVADAS DE TUMOR, ONCOGENES, TRANSDUÇÃO DE SINAL CELULAR, PROTEÍNAS PROTO-ONCOGÊNICAS, PROTEÍNAS QUINASES
ABNT
MIRANDA, Lívia Bassani Lins De et al. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Scientific Reports, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-21419-6. Acesso em: 09 nov. 2024.APA
Miranda, L. B. L. D., Lima, K. C. de, Silva, J. L. C., Traina, F., Kobayashi, S. S., & Machado Neto, J. A. (2022). NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Scientific Reports, 12, 1-11. doi:10.1038/s41598-022-21419-6NLM
Miranda LBLD, Lima KC de, Silva JLC, Traina F, Kobayashi SS, Machado Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells [Internet]. Scientific Reports. 2022 ; 12 1-11.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41598-022-21419-6Vancouver
Miranda LBLD, Lima KC de, Silva JLC, Traina F, Kobayashi SS, Machado Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells [Internet]. Scientific Reports. 2022 ; 12 1-11.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41598-022-21419-6